Search research articles
Contact Us
Filters
Showing results (71-80 of 88) with videos related to
Page
of 9
Sort By:
Psychopharmacology
|
May 9, 2019
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
The Yale Journal of Biology and Medicine
|
July 2, 2020
The Potential for Kratom as an Antidepressant and Antipsychotic
Lindsay E Johnson, Lilian Balyan, Amy Magdalany, et al.
Drug and Alcohol Review
|
October 3, 2019
Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada
Stephanie Lake, Thomas Kerr, Dan Werb, et al.
Experimental and Clinical Psychopharmacology
|
January 12, 2023
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey
Oliver Grundmann, Charles A Veltri, Sara Morcos, et al.
The American Journal of Drug and Alcohol Abuse
|
April 7, 2022
Exploring the self-reported motivations of kratom (<i>Mitragyna speciosa</i> Korth.) use: a cross-sectional investigation
Oliver Grundmann, Charles A Veltri, Diana Morcos, et al.
BMC Musculoskeletal Disorders
|
August 1, 2014
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints
Mary-Ann Fitzcharles, Peter A Ste-Marie, Daniel J Clauw, et al.
Psychopharmacology
|
October 10, 2025
Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days
Michelle St Pierre, Elena Argento, Jordyn Cates, et al.
Journal of Cannabis Research
|
July 4, 2023
Why a distinct medical stream is necessary to support patients using cannabis for medical purposes
Cecilia Costiniuk, Caroline A MacCallum, Michael Boivin, et al.
Arthritis Care & Research
|
November 10, 2015
Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials
Mary-Ann Fitzcharles, Peter A Ste-Marie, Winfried Häuser, et al.
Journal of Affective Disorders
|
January 22, 2019
A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, Canada
Frank Y Chou, Heather L Armstrong, Lu Wang, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 88) with videos related to
Sort By:
Page
of 9
Psychopharmacology
|
May 9, 2019
MDMA-assisted psychotherapy for treatment of PTSD: study design and rationale for phase 3 trials based on pooled analysis of six phase 2 randomized controlled trials
Michael C Mithoefer, Allison A Feduccia, Lisa Jerome, et al.
The Yale Journal of Biology and Medicine
|
July 2, 2020
The Potential for Kratom as an Antidepressant and Antipsychotic
Lindsay E Johnson, Lilian Balyan, Amy Magdalany, et al.
Drug and Alcohol Review
|
October 3, 2019
Guidelines for public health and safety metrics to evaluate the potential harms and benefits of cannabis regulation in Canada
Stephanie Lake, Thomas Kerr, Dan Werb, et al.
Experimental and Clinical Psychopharmacology
|
January 12, 2023
Correlations of kratom (Mitragyna speciosa Korth.) use behavior and psychiatric conditions from a cross-sectional survey
Oliver Grundmann, Charles A Veltri, Sara Morcos, et al.
The American Journal of Drug and Alcohol Abuse
|
April 7, 2022
Exploring the self-reported motivations of kratom (<i>Mitragyna speciosa</i> Korth.) use: a cross-sectional investigation
Oliver Grundmann, Charles A Veltri, Diana Morcos, et al.
BMC Musculoskeletal Disorders
|
August 1, 2014
Rheumatologists lack confidence in their knowledge of cannabinoids pertaining to the management of rheumatic complaints
Mary-Ann Fitzcharles, Peter A Ste-Marie, Daniel J Clauw, et al.
Psychopharmacology
|
October 10, 2025
Daily self-assessment within a regimen of microdosing indicates enhanced psychological functioning on microdosing days relative to non-microdosing days
Michelle St Pierre, Elena Argento, Jordyn Cates, et al.
Journal of Cannabis Research
|
July 4, 2023
Why a distinct medical stream is necessary to support patients using cannabis for medical purposes
Cecilia Costiniuk, Caroline A MacCallum, Michael Boivin, et al.
Arthritis Care & Research
|
November 10, 2015
Efficacy, Tolerability, and Safety of Cannabinoid Treatments in the Rheumatic Diseases: A Systematic Review of Randomized Controlled Trials
Mary-Ann Fitzcharles, Peter A Ste-Marie, Winfried Häuser, et al.
Journal of Affective Disorders
|
January 22, 2019
A longitudinal analysis of cannabis use and mental health symptoms among gay, bisexual, and other men who have sex with men in Vancouver, Canada
Frank Y Chou, Heather L Armstrong, Lu Wang, et al.
Page
of 9